Showing results (881-890 of 2,231) with videos related to
Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|November 9, 2019
LncRNA PTCSC3 Is a Biomarker for the Treatment and Prognosis of Gastric CancerGuodong Zhang, Nannan Chi, Qingfeng Lu, et al.Cancer Biotherapy & Radiopharmaceuticals|January 24, 2020
miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell CarcinomaXiao-Li Liu, Wen-Gu Pan, Kai-Lin Li, et al.Cancer Biotherapy & Radiopharmaceuticals|February 5, 2020
A Genomic Profile of Local Immunity in the Melanoma Microenvironment Following Treatment with α Particle-Emitting Ultrasmall Silica NanoparticlesAleksandra M Urbanska, Raya Khanin, Simone Alidori, et al.Cancer Biotherapy & Radiopharmaceuticals|December 8, 2018
The Effect of PTCH1 on Ovarian Cancer Cell Proliferation and ApoptosisFang Zheng, Xinyi Xiao, Chunmei WangCancer Biotherapy & Radiopharmaceuticals|December 27, 2018
Combined Detection of HER2, Ki67, and GSTP1 Genes on the Diagnosis and Prognosis of Breast CancerBo Song, Lu Wang, Yang Zhang, et al.Cancer Biotherapy & Radiopharmaceuticals|December 27, 2018
A Predictive Scoring Model for Short-Term Local Recurrent Nasopharyngeal Carcinoma Based on Magnetic Resonance ImagingYou-Ming Zhang, Ming-Na Chen, Jian-Ming Gao, et al.Cancer Biotherapy & Radiopharmaceuticals|December 27, 2018
Clinical Value of Positron Emission Tomography-Computed Tomography Combined with Ultrasound in Detection of Primary Tumors in Patients with Malignant AscitesJian Liu, Gang Liu, Xiaolin Liu, et al.Cancer Biotherapy & Radiopharmaceuticals|June 13, 2022
Radiopharmaceutical Quality Control Considerations for Accelerator-Produced Actinium TherapiesDiane S Abou, Patrick Zerkel, James Robben, et al.Cancer Biotherapy & Radiopharmaceuticals|June 29, 2022
Highly Expressed LINC00958 Modulates the Growth and Epithelial-Mesenchymal Transition of Bladder Cancer Cells Through SAPK/JNK Signaling PathwayYing Xiao, Lei He, Yipeng Dong, et al.Cancer Biotherapy & Radiopharmaceuticals|February 21, 2020
miR-634 Decreases the Radioresistance of Human Breast Cancer Cells by Targeting STAT3Bilan Yang, Feng Kuai, Zhijun Chen, et al.Pageof 224